Skip to main content
OpenTrials
Completed

NCT Number: NCT07200635

Test Serum Clinical Study

This 4-week, mono-centric clinical study employed a randomized three-arm design to evaluate the efficacy of a test serum. The study compared three interventions: the test serum used alone, the test serum used in combination with hyaluronic acid (HA) injection, and HA injection alone. It aimed to assess their effects on skin quality and wrinkles in 90 healthy Chinese female subjects aged 25-40. Evaluations were conducted at multiple timepoints through clinical assessments, instrumental measurements, and image analysis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai China-norm Quality Technical Service Co., Ltd.

Shanghai, Shanghai Municipality, 200072, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chinese female with 25-40 years old.
  • All skin types by subjects' self-perceived.
  • Willing to perform HA injection.
  • Did not perform any of the beauty procedure projects in the past 6 months.
  • Lack of hydration, radiance, brightness, smoothness, firmness and elasticity by self-claimed.
  • Presenting with corresponding severity for the attribute evaluated by Dermatologist included:
  • Radiance, smoothness, elasticity, cheek plumpness and firmness: 3≤grade≤6.
  • Global fine lines: 3≤grade.
  • Underneath eye wrinkles: 2≤grade≤5.
  • Forehead wrinkles: 1<grade≤4.
  • Glabella wrinkles: 1<grade.
  • All accept not to use any cosmetics, skincare products, beauty equipment, all topical medications and cleansing products on face at visit days.
  • Did not participate any clinical test or cosmetic product test on skin within 1 months.
  • No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer.
  • In general, good health at the time of the study.
  • Willing and able to participate as evidenced by signing of informed consent & photo release form.
  • Must be willing to comply with all study protocol requirements.

Exclusion criteria

  • Pregnant or breast-feeding woman or woman planning pregnancy during the study.
  • Subject deprived of rights by a court or administrative order.
  • Major subject to a guardianship order.
  • Subject residing in a health or social care establishment.
  • Patient in an emergency setting.
  • Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema).
  • Subject presenting a stable or progressive serious disease (per investigator's assessment).
  • Immuno-compromised subject.
  • Subject with history of allergy to cosmetic or personal care products or ingredients.
  • Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
  • Subject with history of sunlight sensitivity or allergies.
  • Subject regularly practicing aquatic or nautical sports.
  • Subject regularly attending a sauna.
  • Subject with physical highly sensitive constitution.
  • Subject with cardiovascular or circulatory history.
  • Subject with a history of skin cancer or malignant melanoma.
  • Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study.

Treatment and study plan

HA injection

Other

Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.

Facial serum application

Other

Dosage on face: About 0.5g/face for serum.

Primary outcomes

  1. Skin Hydration Level via Corneometer CM825

    Time frame: Measurements are taken at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) , and Day 28 (T28D) .

  2. Skin Barrier Function via Vapometer® (TEWL Measurement)

    Time frame: Measurements are taken at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) , and Day 28 (T28D) .

  3. Skin Elasticity via Cutometer® Dual MPA 580

    Time frame: Measurements are taken at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) , and Day 28 (T28D) .

  4. Facial Skin Redness and Wrinkle Mapping via VISIA-7 Imaging

    Time frame: Images are captured at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) , and Da

  5. 3D Topographical Analysis of Wrinkles and Pores via Antera 3D

    Time frame: Measurements are taken at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) , and Day 28 (T28D) .

  6. Subjective Skin Tolerance and Sensation via Self-Assessment Questionnaire

    Time frame: Questionnaires are administered at Baseline (T0) , 10 minutes post-application (for Group 1 only), 1 hour post-application (T1h) , Day 1 (T1D) , Day 3 (T3D) , Day 7 (T7D) , Day 14 (T14D) , Day 21 (T21D) ,

Sponsors and collaborators

Lead sponsor

ChinaNorm

Industry

Registry information

Official study title

Test Serum 4-Week Clinical Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Oct 1, 2025
Registry last updated
Nov 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.